bluuebunny/crossref_metadata_2025_split huggingface dataset:
Synthesis and Application of Poly(diallyldimethylammonium tribromide) as a Novel Polymeric Brominating Agent
Authors: Hossein Mahdavi , Zahra Kachoei 
Published: November 2010

AbstractIn this study, the synthesis and applications of a new supported tribromide reagent based on poly(diallyldimethylammonium chloride) is reported. This supported tribromide is used in α‐bromoacetalization of ketones, bromination of alkenes and regioselective bromination of activated aromatic compounds. This method is mild and no Br2 and HBr were used. Other advantages of this reagent are stability, high efficiency, simple filtera‐ bility and reusability.
Strong Luminescence Catalytic Solid Substrate Room Temperature Phosphorescence for the Determination of Trace Copper
Authors: Lin Changqing , Zhang Lihong , Zheng Zhiyong , Lin Xuan , Lin Liping , Wang Xinxing , Lin Shaoqin , Liu Jiaming 
Published: November 2010

AbstractUnder the conditions of reacting at 100°C for 8 min and irradiating with the infrared light for 15 min, methylene blue (MEB) could emit weak room temperature phosphorescence (RTP) on the cellulose acetate membrane (CAM) using Pb2+ as the ion perturber in the NH3‐NH4Cl (pH=9.80) solution. MEB was oxidized by H2O2, which caused the RTP of the system to enhance. Cu2+ could catalyze the reaction of H2O2 oxidizing MEB, which caused the RTP of the system to enhance sharply. The ΔIp (Ip0−Ip, the Ip0 and Ip were RTP intensity of the blank reagent and RTP intensity of the test reagent, respectively) of the catalytic system was 133.6, which was 4.1 times larger than that without infrared light irradiation (33.1). Its ΔIp was proportional to the content of Cu2+. Thus, a new catalytic solid substrate room temperature phosphorimetry (SSRTP) for the determination of trace copper has been established. The limit of quantization (LOQ) of this method was 0.12 ag·spot−1 (sample volume: 0.40 µL·spot−1, corresponding concentration: 3.0×10−16 g·mL−1), showing high sensitivity. This method not only has been successfully applied to the determination of trace copper in the tobacco, tea and human serum, but also could predict human diseases. The catalytic reaction was first order reaction, whose activation energy (E) was 18.17 kJ·mol−1 and rate constant (k) was 3.4×10−4 s−1. At the same time, the mechanism of catalytic SSRTP for the determination of trace copper was discussed.
Design and Synthesis of Biotinylated Troglitazone as an Active Affinity Probe
Authors: Li Xin , Li Xiaoqi , Tang Hong , Nan Fajun 
Published: November 2010

AbstractA biotin‐tagged analogue of troglitazone was designed, synthesized and applied to affinity chromatography to pulldown EGFR from 293T cell lysates overexpressing EGFR, a membrane protein assumed to be troglitazone's direct binding target by previous work. The results indicate the feasibility of the biotinylated probe as a vigorous tool to clarify the molecular mechanisms for troglitazone's antitumor activities.
Sodium Dithionite Initiated Addition‐lactonization of 2‐Acyl‐ amino‐4‐pentenoic Acids with Fluoroalkyl Iodides to Synthesize 4‐Fluoroalkyl‐2‐acylamino‐4‐butyrolactones
Authors: Yang Xueyan , Yang Xianjin , Zhu Shengjie , Ye Lingling , Chen Yang , Chen Guanlong , Wu Fanhong 
Published: November 2010

Abstract4‐Fluoroalkyl‐2‐acylamino‐4‐butyrolactones were afforded in moderate yields by the sodium dithionite initiated one‐pot addition‐lactonization reaction of polyfluoroalkyl iodides with 2‐acylamino‐4‐pentenoic acids.
Low‐temperature Heat Capacities and Thermodynamic Properties of the Solid State Complexes (C2H10N2)MCl4 (s) (M=Cu and Cd)
Authors: Cao Yanping , Chen Jingtao , Di Youying , He Donghua , Dan Wenyan , Liu Yupu 
Published: November 2010

AbstractThe tetrachlorocuprate(II) ethylenediammonium and tetrachlorocadmate(II) ethylenediammonium were synthesized. Chemical analysis, elemental analysis, and X‐ray crystallography were applied to characterize the compositions and crystal structures of the two complexes. The lattice potential energies and the radiuses of the anions of two complexes were calculated to be UPOT[(C2H10N2)CuCl4]=1810.19 kJ·mol−1, UPOT[(C2H10N2)CdCl4]=1784.39 kJ·mol−1, r[(CuCl4)2−]=0.308 nm, and r[(CdCl4)2−]=0.321 nm from the data of the crystal structure, respectively. Low‐temperature heat capacities of the two complexes were measured by a precision automatic adiabatic calorimeter with the small sample over the temperature range from 78 to 400 K, respectively. Two polynomial equations of heat capacities against the temperatures were fitted by least square method: Cp,m[(C2H10N2)CuCl4, s] =213.553+118.578X−5.816X2+4.392X3+0.276X4 and Cp,m[(C2H10N2)CdCl4, s] =190.927+98.501X−7.931X2+0.657X3+3.834X4, in which X= (T−239)/161. Based on the fitted polynomial equations, the smoothed heat capacities and thermodynamic functions of the two complexes relative to the standard reference temperature 298.15 K were calculated at intervals of 5 K.
A self‐calibrating PARACEST MRI contrast agent that detects esterase enzyme activity
Authors: Li Yuguo , Sheth Vipul R. , Liu Guanshu , Pagel Mark D. 
Published: November 2010

AbstractThe CEST effect of many PARACEST MRI contrast agents changes in response to a molecular biomarker. However, other molecular biomarkers or environmental factors can influence CEST, so that a change in CEST is not conclusive proof for detecting the biomarker. To overcome this problem, a second control CEST effect may be included in the same PARACEST agent, which is responsive to all factors that alter the first CEST effect except for the biomarker to be measured. To investigate this approach, a PARACEST MRI contrast agent was developed with one CEST effect that is responsive to esterase enzyme activity and a second control CEST effect. The ratio of the two CEST effects was independent of concentration and T1 relaxation, so that this agent was self‐calibrating with respect to these factors. This ratiometric method was dependent on temperature and was influenced by MR coalescence as the chemical exchange rates approached the chemical shifts of the exchangable protons as temperature was increased. The two CEST effects also showed evidence of having different pH dependencies, so that this agent was not self‐calibrating with respect to pH. Therefore, a self‐calibrating PARACEST MRI contrast agent can more accurately detect a molecular biomarker such as esterase enzyme activity, as long as temperature and pH are within an acceptable physiological range and remain constant. Copyright © 2010 John Wiley & Sons, Ltd.
Cell Biology of Secretion
Authors: Dannies Priscilla S. 
Published: November 2010

AbstractThe sections in this article are:Intracellular Transport in VesiclesMembrane Fusion and ExocytosisInvestigations in Synaptic VesiclesInvestigations in YeastReconstituted Systems of TransportConvergence of Separate ApproachesCalcium Dependence of Stimulated Neurotransmitter ReleaseDocking Vesicles to the Correct MembraneOther Fusion MechanismsEvidence for SNAP‐NSF‐Mediated Docking/Fusion With Dense Core GranulesExocytosis in Endocrine CellsMembrane Budding and EndocytosisBudding Involving ClathrinBudding Involving COPI/ARFEndocytosis in Endocrine CellsFormation of Secretory Granules in Endocrine Cells
Receptor Identification and Characterization
Authors: Limbird Lee E. , Motulsky Harvey 
Published: November 2010

AbstractThe sections in this article are:Identification of Receptors Based on Functional PropertiesSchild AnalysisIdentification of Receptors with Radioligand BindingChoosing the Biological PreparationChoosing a RadioligandSeparating Bound From Free RadioligandIrrelevant BindingEstablishing That the Radioligand Binding Detected Reflects Interaction With the Physiologically Significant ReceptorAnalysis of Radioligand Binding Data Based on the Law of Mass ActionFractional OccupancyAssumptions Inherent in the Law of Mass ActionSaturation Binding StudiesDefining Nonspecific Binding in a Radioligand Binding AssayDefining The Specificity of Radioligand Binding Using Competitive Binding AnalysisAnalyzing Competitive Binding DataCalculating the KiFrom the IC50Homologous Competitive Binding Curves Permit an Assessment of Both Kdand BmaxKinetic Analysis of Radioligand Binding ExperimentsStudies of Radioligand DissociationStudies of Radioligand AssociationComplex Binding PhenomenaCompetitive Binding Experiments With Two (or More) Receptor SitesSaturation Binding Experiments With Two Receptor SitesComparing One‐ and Two‐Site ModelsThe Slope Factor of a Competitive Binding CurveUsing Dissociation Experiments to Investigate Complex BindingDistinguishing Between Independent Receptor Subtypes and Negative CooperativityEvaluating Allosteric PhenomenaObtaining Independent Data to Clarify the Biological Origin of Complex Binding PhenomenaAgonist Binding and the Ternary ComplexSummary
Membrane Receptor–Linked Disease States
Authors: Nebes V. , Wall J. 
Published: November 2010

AbstractThe sections in this article are:Genetic Disorders of Receptor and Effector MoleculesTypes of ReceptorClinical DisordersC ProteinsReceptors and OncogenesAntibodies Against Receptors and Autoimmune DisordersSeven‐Transmembrane‐Receptor/G Protein–Coupled DisordersThyroid‐Stimulating Hormone Receptor/Toxic Thyroid Hyperplasia/Thyroid‐Stimulating Hormone ResistanceLuteinizing Hormone Receptor/Precocious Puberty/ Leydig Cell HypoplasiaAdrenocorticotropic Hormone Receptor/Familial Glucocorticoid DeficiencyArginine Vasopressin/Nephrogenic Diabetes InsipidusRhodopsin/Retinifis PigmentosaParathyroid Hormone/Parathyroid Hormone–Related Peptide Receptor/Jansen‐Type Metaphyseal Chondrodysplasiaβ3‐Adrenergic Receptor/ObesityGrowth Hormone–Releasing Hormone ReceptorSomatostatin ReceptorMutations of G ProteinsGαsMutations/Albright Hereditary OsteodystrophySingle‐Transmembrane‐Receptor–Coupled DiseasesInsulin Receptor/Leprechaunism/Rabson‐Mendenhall Syndrome/Type A Insulin ResistanceGrowth Hormone Receptor/Laron DwarfismInsulin‐Like Growth Factor‐1 ReceptorFour‐Transmembrane‐Segment Receptor DiseasesGamma‐Aminobutyric Acid and Serotonin ReceptorsAcetylcholine Receptor/Slow‐Channel SyndromeAbnormal Recognition, Regulation, and Signaling PathwaysReceptor‐Specific Cross‐Over DiseaseHyperprolactinemia SyndromeTrophoblastic Tumors/Human Chorionic GonadotropinNon‐Islet Cell Neoplasms/Type II Insulin‐Like Growth FactorOncogenic Receptor DefectsThyroid‐Stimulating Hormone Receptor/ Thyroid AdenomasGαsMutations/McCune‐Albright SyndromeDisorders ofRasandRas‐Like Proto‐oncogenesAntireceptor Antibodies and Autoimmune DiseaseEffect of Antireceptor AntibodiesThyroid‐Stimulating Hormone Receptor Antibodies and Graves' DiseaseThyroid Growth–Stimulating AntibodiesInsulin Receptor Antibodiesβ‐Adrenergic Receptor AntibodiesMyasthenia GravisOther Receptor Antibodies
Steroid Hormone Receptor Families
Authors: Hurd Cliff , Moudgil V. K. 
Published: November 2010

AbstractThe sections in this article are:Molecular Composition of Receptor Proteins: Primary Structural Homologies and Functional DomainsThe A/B Region of Steroid Receptors Contains a Hormone‐Independent Activation FunctionThe C Region Encodes a Specific DNA‐Binding FunctionThe D Region (the Hinge Domain) Contains a Nuclear Localization SignalThe E/F Region Contains the Hormone‐Binding Domain, a Dimerization Motif, Steroid Receptor Repressor Activity, and a Receptor Agonist‐Dependent Transcriptional Activation FunctionReceptor‐Associated Proteins and the Oligomeric Structure of Steroid ReceptorsMajor Heat Shock ProteinsCross‐Talk with Other Signal‐Transduction PathwaysCyclic Adenosine Monophosphate and Activation of Steroid ReceptorsTranscriptional InterferencePathways That Converge on the Estrogen ReceptorRole of Phosphorylation in Steroid Receptor Structure and FunctionSites of Phosphorylation, Functional Significance, and Regulatory KinasesEstrogen Receptor PhosphorylationProgesterone Receptor PhosphorylationGlucocorticoid Receptor PhosphorylationVitamin D Receptor PhosphorylationTransactivation by Steroid ReceptorsAntihormones and Their Modes of ActionRU486, an Agonist/Antagonist of Progesterone ReceptorZK98299, a Full Antagonist of Progesterone ReceptorAntiestrogens and Estrogen Receptor FunctionSteroid Receptors and Clinical Management of CancerCancer: Molecular AspectsBreast Cancer, Tumor Suppressors, and EstrogenParadoxical Effects of Estrogen: Molecular AspectsFuture Directions
Cellular Localization of Receptors Mediating the Actions of Steroid Hormones
Authors: Judy Barbara M. , Welshons Wade V. 
Published: November 2010

AbstractThe sections in this article are:Nuclear Localization of Most Unliganded Steroid ReceptorsBasis for the Initial Two‐Step Translocation Model of Steroid Action and LocationCurrent Nuclear Localization Model for Most Steroid ReceptorsGlucocorticoid Receptor LocalizationNuclear Import and Export of Steroid ReceptorsEntry of Proteins Into the NucleusNuclear Localization SignalsMechanism of Nuclear ImportNuclear Export and Nucleocytoplasmic ShuttlingConclusionsAlternate Steroid Receptors and Nongenomic Steroid ResponsesEstrogen Receptor‐βGlucocorticoidsMineralocorticoidsProgesteroneEstrogen1,25‐Dihydroxyvitamin D3TestosteroneConclusions
Autocrine/Paracrine Intermediates in Hormonal Action and Modulation of Cellular Responses to Hormones
Authors: Denef Carl 
Published: November 2010

AbstractThe sections in this article are:Methods to Explore Local ControlLocal Control in the Anterior PituitaryEvidence for Intercellular Communication in the Anterior PituitaryPutative Paracrine FactorsLocal Control in the Adrenal Cortex and MedullaMorphological Correlates of Medulla–Cortex InteractionsPutative Paracrine and Autocrine Factors in the MedullaPutative Paracrine and Autocrine Factors in the Adrenal CortexLocal Control in the TestisEvidence for Functional Interaction Between Different Testicular Cell TypesLocal Control by SteroidsLocal Control by Regulatory PeptidesLocal Control by Biogenic Amines and Nitrous OxideLocal Control by Polypeptide Growth FactorsLocal Control by Substances From Testicular MacrophagesLocal Control in the OvaryEvidence for Functional Interaction Between Thecal Cells and Granulosa CellsLocal Control by SteroidsLocal Control by Regulatory PeptidesOpioid PeptidesLocal Control by Polypeptide Growth FactorsParacrine Factors Mediating Actions of Thyroid and Steroid HormonesLocal Control in Pancreatic Endocrine CellsAre Insulin, Glucagon, Somatostatin, and Pancreatic Polypeptide Paracrine and Autocrine Factors in the Pancreatic Islets?Local Control by Other Regulatory PeptidesLocal Control by Biogenic AminesLocal Control by Polypeptide Growth FactorsLocal Control in the Thyroid GlandLocal Control by Regulatory PeptidesLocal Control by Polypeptide Growth FactorsLocal Control in the Parathyroid Gland
Apoptosis
Authors: Hsu Sheau Yu , Hsueh Aaron J. W. 
Published: November 2010

AbstractThe sections in this article are:Apoptotic Cell Death Shows Conserved Morphological and Biochemical ChangesNuclear Condensation and Ladder Pattern of DNA FragmentationCytoplasmic Shrinkage and Plasma Membrane BlebbingNuclear and Cytoplasmic AlterationsPhagocytosisCellular Mechanisms of Apoptosis Conserved During Evolution: Nematode as a Genetic ModelGenes Regulating ApoptosisTheced‐9/bcl‐2Gene FamilyTheced‐3/caspaseGene FamilyDeath Domain‐Containing ProteinsOther Apoptosis Regulatory GenesExtracellular Signaling of ApoptosisApoptosis Induction Is Cell Type‐SpecificThe Mammalian Ovary ModelFas‐Ligand/Fas Antigen and ApoptosisConclusion
Production, Action, and Degradation of Somatostatin
Authors: Patel Yogesh C. , Liu Jun‐Li , Galanopoulou Aristea , Papachristou Dimitri N. 
Published: November 2010

AbstractThe sections in this article are:Anatomical Distribution of Somatostatin CellsLocalizationPancreatic Somatostatin CellsBiosynthesis, Processing, and Intracellular TargetingSomatostatin Genes and Gene ProductsRegulation of Islet SomatostatinRegulation of SecretionRegulation of Gene ExpressionActions and Mechanism of Action of SomatostatinIslet Cell ActionsExtra‐Islet ActionsSomatostatin AgonistsSomatostatin ReceptorsMetabolism of SomatostatinCirculating SomatostatinIslet Somatostatin FunctionParacrine RegulationRegulation via the MicrocirculationGap Junctional CouplingIndependent Regulation by Somatostatin‐14 and Somatostatin‐28Somatostatin and DiabetesExperimental Insulinopenic DiabetesExperimental Hyperinsulinemic DiabetesHuman DiabetesConcluding Remarks
Amylin and Related Proteins: Physiology and Pathophysiology
Authors: Cooper Garth J. S. 
Published: November 2010

AbstractThe sections in this article are:Protein Chemistry of AmylinIsolation, Structure, Nomenclature, and Evolutionary RelationshipsChemical SynthesisMolecular Structure of Soluble AmylinAmylin as the Monomer of Islet AmyloidMolecular BiologyPreproamylinStructure and Chromosomal Location of the Human Amylin GeneA Disease‐Associated Mutation in Human AmylinBiosynthesis and Secretion of AmylinMeasurement of Amylin ConcentrationsTissue Localization and ContentRegulation of BiosynthesisAmylin in Extra‐Islet TissuesCirculating Concentrations and Pancreatic SecretionEffects of Secretion ModulatorsAmylin Secretion in HumansThe Amylin Family: Role in the Regulation of Fuel MetabolismInsulin Resistance In VivoActions in Skeletal MuscleRole of Calcitonin Gene‐Related Peptide in Skeletal Muscle MetabolismActions in the LiverAdipose TissueRegulation of Pancreatic FunctionEndocrine PancreasExocrine PancreasRegulation of The Gastrointestinal TractEffects on Gastric FunctionIntestinal FunctionActions in The Central Nervous System: Modulation of AppetiteActions in The Cardiovascular SystemCalcitonin Gene‐Related PeptideAdrenomedullinBiological Actions of Adrenomedullin in the Cardiovascular SystemVascular Actions of AmylinRenal FunctionRole of Amylin in the Regulation of Renal FunctionAdrenomedullin: Roles in Renal Function and Sodium HomeostasisEffects on Calcium Metabolism and BoneActions of AmylinOther Biological ActionsRespiratory SystemEffects in Endocrine Tissues Other than PancreasEffects in the Immune SystemReceptors for Amylin and Related ProteinsReceptor NomenclaturePharmacological and Biochemical StudiesCalcitonin ReceptorsSpecific Calcitonin Gene‐Related Peptide Binding Sites that Can Interact with AmylinAmylin Binding to Skeletal Muscle and LiverBiochemical Characterization of Putative Amylin and Calcitonin Gene‐Related Peptide ReceptorsDisease AssociationsInsulin‐Dependent Diabetes MellitusAnimal Models of Insulin Resistance, Obesity, and DiabetesObesity and Non‐Insulin‐Dependent Diabetes Mellitus in HumansOther Diabetic SyndromesAmylin in Endocrine NeoplasmsRelationship to AgingOther DiseasesConclusion and Future Prospects
Insulin Receptor Tyrosine Kinase
Authors: Czech Michael P. , Van Renterghem Barbara , Sleeman Mark W. 
Published: November 2010

AbstractThe sections in this article are:Insulin Receptor StructureInsulin BindingReceptor Endocytosis MotifsTyrosine Kinase CharacteristicsInsulin Receptor SubstratesPleckstrin Homology DomainsPhosphotyrosine‐Binding DomainsSrc Homology 2 Domains
Molecular Aspects of Insulin Signaling
Authors: Emkey Renee , Kahn C. Ronald 
Published: November 2010

AbstractThe sections in this article are:The Insulin ReceptorInsulin Receptor Substrate 1Role of Insulin Receptor Substrate 1 Sequence Polymorphisms in Humans and the Pathophysiology of DiabetesGrowing Family of Insulin Receptor SubstratesComplementary and Alternative Pathways in Insulin SignalingA Polygenic Model of Non‐Insulin‐Dependent Diabetes MellitusDifferential Subcellular Localization of Insulin Receptor Substrates 1 and 2Insulin‐Stimulated Insulin Receptor Substrate InteractionsSrc Homology‐2 Domain‐Mediated InteractionsNon‐Src Homology‐2 Domain‐Mediated InteractionsSerine/Threonine Protein Kinases and the Final Biological Effects of InsulinDifferential Regulation of Insulin Receptor Substrates 1 and 2 and Phosphatidylinositol‐3‐KinaseLinking Early Steps in Insulin Action to Late Postreceptor EventsInsulin Stimulation of Glucose TransportCoupling of Insulin Action to the Nucleus of the CellCross‐Talk Between the Insulin‐Signaling Network and Other Hormonal Response PathwaysFuture Perspectives
Regulation of Protein Metabolism in Muscle
Authors: Jefferson Leonard S. , Vary Thomas C. , Kimball Scot R. 
Published: November 2010

AbstractThe sections in this article are:Efficiency of Protein Synthesis: Translational ControlRole of Insulin in the Regulation of Translation InitiationInteractive Roles of Insulin and Amino Acids in the Regulation of Translation InitiationInteractive Roles of Insulin and Other Hormones in the Regulation of Protein Synthesis in Skeletal MuscleCapacity for Protein Synthesis: Ribosomal BiogenesisRole of Insulin in the Regulation of rRNA Gene TranscriptionRole of Insulin in the Regulation of Synthesis of Ribosomal ProteinsProtein DegradationThe Lyosomal SystemCalcium Activated ProteinasesThe Ubiquitin‐Proteasome SystemFuture Perspectives
Regulation of Protein Metabolism in Liver
Authors: Mortimore Glenn E. , Kadowaki Motoni 
Published: November 2010

AbstractThe sections in this article are:Turnover of Cellular Protein and RNADetermination of General Protein TurnoverClasses of General Protein TurnoverCytoplasmic RNA TurnoverAutophagyMacroautophagyMicroautophagyA Unified Mechanism of Macro‐ and Microautophagic ProteolysisRegulation of AutophagyControl of Macroautophagy by Amino AcidsHormonal Control of Cellular Protein TurnoverControl of Macro‐ and Microautophagy during Starvation and RefeedingOverview
Regulation of Glycogen Metabolism
Authors: Roach Peter J. , Skurat Alexander V. , Harris Robert A. 
Published: November 2010

AbstractThe sections in this article are:GlycogenStructureFunctionPathways of Glycogen MetabolismOverviewGlycogen BiosynthesisGlycogen Synthase and Branching EnzymeGlycogenolysis and Debranching EnzymeGlycogen Particles and Physical Interactions among Glycogen‐Metabolizing ProteinsHormonal Regulation of Glycogen Synthesis in MuscleInsulinMechanisms of Insulin ActionEpinephrineRegulation of Glycogen Metabolism in LiverOverviewTwo Pathways of Glycogen Synthesis in LiverGlucose Transport Is Not Regulated in LiverRegulation of Glucokinase ActivityRegulation of Glycogen Synthase ActivityRegulation of Glucose‐6‐Phosphatase ActivityRegulation of Glycogen Phosphorylase ActivityConclusion
Genetic Regulation of Glucose Metabolism
Authors: Sutherland Calum , O'Brien Richard , Granner Daryl K. 
Published: November 2010

AbstractThe sections in this article are:Glucagon and Insulin ActionSignaling from the Cell Membrane to the NucleusDNA Elements and Their Binding ProteinsGenetic Regulation of the Hepatic Gluconeogenic EnzymesGlucose‐6‐PhosphataseFructose‐1,6‐BisphosphatasePhosphoenolpyruvate CarboxykinaseGenetic Regulation of the Hepatic Glycolytic EnzymesGlucokinase6‐Phosphofructo‐1‐KinasePyruvate Kinase6‐Phosphofructo‐2‐Kinase/Fructose‐2,6‐BisphosphataseGenetic Regulation of Other Proteins Involved in Glucose MetabolismGlyceraldehyde‐3‐Phosphate DehydrogenaseTyrosine AminotransferaseGLUT‐1 Glucose TransporterHexokinase IIGenetic Regulation of Lipogenic EnzymesAcetyl‐CoA CarboxylaseFatty Acid SynthaseMalic EnzymeConclusions and Perspectives
Control of Glucose Production in vivo by Insulin and Glucagon
Authors: Cherrington Alan D. 
Published: November 2010

AbstractThe sections in this article are:Assessment of Glucose Production in vivoGlucagon and Glucose ProductionEffects of Basal GlucagonEffects of Increments in GlucagonInsulin and Glucose ProductionEffects of Insulin DeficiencyEffects of Increases in InsulinIntegration of Insulin and Glucagon's Effects